CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹460 Cr | ₹522 Cr | ₹350 Cr | ₹274 Cr | ₹232 Cr |
What is the latest Sundry Debtors ratio of CONCORD BIOTECH ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹460 Cr |
| Mar2025 | ₹522 Cr |
| Mar2024 | ₹350 Cr |
| Mar2023 | ₹274 Cr |
| Mar2022 | ₹232 Cr |
How is Sundry Debtors of CONCORD BIOTECH Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹460 Cr | -11.78 | |
| Mar2025 | ₹522 Cr | 49.21 | |
| Mar2024 | ₹350 Cr | 27.71 | |
| Mar2023 | ₹274 Cr | 17.91 | |
| Mar2022 | ₹232 Cr | - | |
Compare Sundry Debtors of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹15,088.6 Cr | -2.8% | 5.5% | -16.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,826.0 Cr | -1.6% | -2.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,019.0 Cr | 1.5% | 12.8% | 48.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,875.0 Cr | -0.9% | -0.8% | 35.3% | Stock Analytics | |
| CIPLA | ₹112,773.0 Cr | -1.6% | -5.2% | -11.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,570.9 Cr | -2.2% | -2.3% | -8.2% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -2.8% |
5.5% |
-16.3% |
| SENSEX | -1.1% |
-3.6% |
-5.3% |
You may also like the below Video Courses